Skip to content

A first-in-human study to investigate safety and tolerability of SAR446959 in participants with osteoarthritis of the knee

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-514015-96-00
Acronym
SAD18258
Enrollment
230
Registered
2024-11-12
Start date
2024-11-20
Completion date
2025-12-18
Last updated
2025-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Interventions

None listed

Sponsors

Sanofi-Aventis Recherche & Developpement
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Germany

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026